This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Rough endoplasmic reticulum

Authoring team

Rough endoplasmic reticulum is a type of endoplasmic reticulum in which the cytoplasmic, membrane-lined cavities are covered with ribosomes.

The ribosomes are attached to the outer, cytoplasmic surface of the rER by specialized protein receptors. The ribosomes may be linked along the membrane surface by a strand of messenger RNA to create a polyribosome. The ribosomes are the main reason rER takes up basophilic stains for light microscopy.

The rER functions to produce and compartmentalise proteins, lipids and other cellular constituents. Polypeptide chains are manufactured at the ribosome and then are either:

  • set free for passage into the cytoplasm
  • incorporated into the membrane of the rER for further packaging into plasma membrane or membrane or organelles throughout the body
  • extruded into the cisternal space of the rER for later packaging into organelles e.g. lysosome, or extracellular secretion

There are a number of non-ribosomal proteins in the membrane of the rER which are involved in further processing molecules e.g. post-translational glycosylation, active transport of lipid molecules across the rER membrane.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.